News Channels

06 Jul 2018 Eisai and Biogen Announce Positive Topline Results of the Final Analysis for BAN2401 At 18 Months
05 Jul 2018 Zynerba Pharmaceuticals Announces Top Line Results from ZYN001 THC-Prodrug Patch Phase 1 Study
05 Jul 2018 European Commission Approves Expanded Indication for Sprycel (dasatinib) to Include Treatment of Children with Philadelphia Chromosome-Positive Chronic Myeloid Leukemia in Chronic Phase
04 Jul 2018 Abivax releases positive top line data from ABX464-005 phase 2a study in HIV infection
04 Jul 2018 FDA Approves ARISTADA INITIO™ for the Initiation of ARISTADA® for Schizophrenia
04 Jul 2018 FDA Approves XEOMIN® (incobotulinumtoxinA) for Adult Patients with Sialorrhea
04 Jul 2018 First Volunteers Dosed in Phase I Clinical Trial of PBT434, Prana’s Lead Therapy for Parkinsonian Diseases
04 Jul 2018 Anavex Life Sciences Receives Approval To Initiate Phase 2b/3 Clinical Trial of ANAVEX®2-73 for the Treatment of Early Alzheimer’s Disease
04 Jul 2018 Forendo Pharma Initiates Phase I Study for Potential New, Targeted Treatment for Endometriosis
03 Jul 2018 NewLink Genetics Announces Positive Updated Phase 1 Data with Indoximod Plus Radio-Immunotherapy for Pediatric Patients with DIPG Presented at ISPNO 2018
03 Jul 2018 CHMP issues positive opinion to expand Jardiance®, Synjardy® and Glyxambi® labels to include positive effects on cardiovascular and renal outcomes
03 Jul 2018 FDA Grants Priority Review to Merck’s Supplemental Biologics License Application for KEYTRUDA® (pembrolizumab) in Combination with Chemotherapy as First-Line Treatment for Metastatic Squamous Non-Small Cell Lung Cancer
03 Jul 2018 Advicenne Confirms ADV7103’ Safety and Efficacy after 24 Months in the Phase III Extension Study
03 Jul 2018 TRIGR Therapeutics and ABL Bio Announce Global Oncology Collaboration on Pipeline of Next Generation Therapeutic Antibodies
03 Jul 2018 CHMP recommends EU marketing authorization for Veyvondi® [vonicog alfa, recombinant von Willebrand factor] for adults with von willebrand disease
03 Jul 2018 Conatus Pharmaceuticals’ Pan-caspase Inhibitor Emricasan Improves Survival and Portal Hypertension in a Mouse Model of Cirrhosis
03 Jul 2018 New studies confirm anti-CD160 antibodies are potential therapeutics for ophthalmic diseases
03 Jul 2018 Neovacs announces the results of its phase IIb study for IFNalpha kinoid in the treatment of lupus which allows to proceed with the clinical development into phase III
03 Jul 2018 Aslan Pharmaceuticals submits clinical trial authorisation application for first in man studies for ASLAN004
02 Jul 2018 VarmX Raises € 12.5 Million to Develop Modified Blood Coagulation Factor X for Treating Severe Bleeding in Patients Using Anti-Coagulants

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2017 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up